ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted RSV Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomized Controlled Trial.

Reynaldo Chandler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.